Plain-English translation of NCT07788456 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Phase
Post-approval monitoring
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Enrollment target
~38 participants
Started
June 2026
Primary completion
May 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xiaofan Liu
Thrombosis and Haemostasis Diagnosis Treatment Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.